AI Pathology
Caris Life Sciences alternatives
12 tools that we compared head to head with Caris Life Sciences in a written verdict. Each row says who the tool suits, according to that verdict, and links to the full comparison.
The list is not a ranking. Tools in the same category come first, then every group is in alphabetical order. A tool that is no longer sold is left out.
aetherAI
Series B of NT$765M in 2024, led by CDIB Capital; viewer software and AI modules for pathology labs
See the review for plans
Full comparison
Artera
ArteraAI Breast cleared as K254115; prostate and breast prognosis from biopsy slides
See the review for plans
Full comparison
Freenome
PMA P250029 approved July 2026; vendor reports 81.1% colorectal cancer sensitivity
See the review for plans
Full comparison
GRAIL
Galleri screens adults 50 and older; fDA panel voted 7 to 2 with 1 abstention on benefit-risk
See the review for plans
Full comparison
Ibex Medical Analytics
Prostate Detect cleared under K241232, January 2025; open API to scanners, image management and LIS
See the review for plans
Full comparison
Indica Labs HALO AI
HALO AP Dx has two 510(k) clearances; cleared with Aperio GT 450 DX and NanoZoomer S360MD
See the review for plans
Full comparison
PathAI AISight
AISight Dx cleared for primary diagnosis, K243391; hamamatsu S360MD and Leica GT 450 DX scanners
See the review for plans
Full comparison
Proscia Concentriq
SOC 2 Type II announced December 2025; life sciences line plus clinical case review
See the review for plans
Full comparisonSectra Pathology
Sectra describes IDS7 as one viewer for pathology, radiology, genomics; supports DICOM and vendor-neutral whole-slide images
See the review for plans
Full comparison
Tempus Digital Pathology
Prostate Detect FDA-authorized and CE-IVDR; breast, lymph node and GI tools are research use only
See the review for plans
Full comparison
Vesta
Vesta BCGPredict for non-muscle-invasive bladder cancer; vendor says report arrives about 3 days after receipt
See the review for plans
Full comparison
Visiopharm
CE-IVD apps for ER, PR, HER2 and Ki-67; iSO 13485 certificate valid to December 2027
See the review for plans
Full comparison